OneCell Medical
Multi-parametric Single-cell Analysis Device
Health Tech & Life Sciences
Non Active, May 2023 ceased to operate
Company Overview
Snapshot
Founded in January 2017 by Prof. Uri Sivan, OneCell Medical operates with 1–10 employees. The company raised $1.4 million across one funding round from 3 investors. OneCell Medical ceased operations in May 2023.
Business overview
OneCell Medical develops a multi-parametric single-cell analysis device designed to simultaneously capture thousands of cells and immune-phenotype/characterize each cell, as well as provide the RNA sequence of a desired target. This technology is highly relevant to personalized medicine, serving the Health Tech & Life Sciences sector, particularly in medical technologies, diagnostics, and oncology.
Log in to access full profile ›Company Intelligence Q&A
- What is OneCell Medical's primary focus?
- OneCell Medical focuses on developing a multi-parametric single-cell analysis device for immune-phenotyping, cell characterization, and RNA sequencing, with applications in personalized medicine.
- When was OneCell Medical founded?
- OneCell Medical was founded in January 2017.
- Who is a co-founder of OneCell Medical?
- Prof. Uri Sivan is a co-founder of OneCell Medical.
- What was OneCell Medical's last known funding amount?
- OneCell Medical raised $1.4 million in May 2019. This was a Seed round.
- What is the current operational status of OneCell Medical?
- OneCell Medical ceased to operate in May 2023.